Aluminum Hydroxide / Magnesium Hydroxide / Simethicone Dosage

The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Dyspepsia

Initial:
Al hydroxide/Mg hydroxide/simethicone 400 mg-400 mg-40 mg to 1600 mg-1600 mg-160 mg four times daily.

The maximum daily dose Al hydroxide/Mg hydroxide/simethicone is 4800 mg-4800 mg-480 mg four times a day.

Usual Adult Dose for Flatulence

Initial:
Al hydroxide/Mg hydroxide/simethicone 400 mg-400 mg-40 mg to 1600 mg-1600 mg-160 mg four times daily.

The maximum daily dose Al hydroxide/Mg hydroxide/simethicone is 4800 mg-4800 mg-480 mg four times a day.

Usual Pediatric Dose for Dyspepsia

>12 years: Al hydroxide/Mg hydroxide/simethicone 400 mg-400 mg-40 mg to 800 mg-800 mg-80 mg four times daily.

The maximum daily dose of Al hydroxide/Mg hydroxide/simethicone is 4800 mg-4800 mg-480 mg four times a day.

Usual Pediatric Dose for Flatulence

>12 years: Al hydroxide/Mg hydroxide/simethicone 400 mg-400 mg-40 mg to 800 mg-800 mg-80 mg four times daily.

The maximum daily dose of Al hydroxide/Mg hydroxide/simethicone is 4800 mg-4800 mg-480 mg four times a day.

Renal Dose Adjustments

If kidney disease present, ask a doctor before use.

Dose Adjustments

A dose of Al hydroxide/Mg hydroxide/simethicone 400 mg-400 mg-40 mg will neutralize 19.4 mEq of stomach acid.

Do not use maximum daily dose for more than 2 weeks.

Precautions

The most common adverse effect associated with aluminum antacids is constipation.

Magnesium containing antacids commonly cause a laxative effect.

Patients with renal failure may accumulate aluminum with chronic use. Serum aluminum levels should be monitored or another antacid chosen.

Elevated tissue aluminum levels contribute to the development of the dialysis encephalopathy and osteomalacia syndromes.

Do not use drug before consulting with a doctor if you have kidney disease.

Aluminum forms insoluble complexes with phosphate in the gastrointestinal tract, thus decreasing phosphate absorption which can lead to hypophosphatemia. In patients on hemodialysis who are maintained on aluminum antacids, serum phosphate concentrations should be monitored at monthly or bimonthly intervals.

Other Comments

Shake the suspension well before using.

Hide
(web4)